A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 <sup>+</sup> T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma-Reference-Cited by-同舟云学术

A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 ⁺ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma

Published:2023-05-10 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Rezapour Azar¹^ORCID,Rydbeck Daniel²³,Byvald Fabian¹^ORCID,Tasselius Viktor³⁴^ORCID,Danielsson Gustaf⁵,Angenete Eva²³^ORCID,Yrlid Ulf¹^ORCID

Affiliation:

1. Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

2. Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden

3. Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

4. Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

5. Department of Clinical Pathology and Genetics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

Funder

Mary von Sydow’s Research Fund

Swedish Cancer Society

Swedish State under the agreement between Swedish government and the county councils—the ALF agreement

Swedish Research Council

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2209473

Reference41 articles.

1. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis

2. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

3. Immunoscore and its introduction in clinical practice

4. Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer

5. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study